Treatment effects of sleep apnoea: where are we now?

Buyse B., the participants of working group 2

Source: Eur Respir Rev 2007; 16: 146-168
Journal Issue: December 2007 - 17 (106)
Disease area: Sleep and breathing disorders

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Buyse B., the participants of working group 2. Treatment effects of sleep apnoea: where are we now?. Eur Respir Rev 2007; 16: 146-168

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Sleep, sleep-disordered breathing and metabolic consequences
Source: Eur Respir J 2009; 34: 243-260
Year: 2009



Pharmacological management of sleep-disordered breathing
Source: Eur Respir Mon 2010; 50: 321-339
Year: 2010


Sleep apnoea and driving: how can this be dealt with?
Source: Eur Respir Rev 2007; 16: 189-195
Year: 2007



Treatment of obstructive and central sleep apnoea in heart failure: current concepts and perspectives
Source: Annual Congress 2005 - PG12 - Sleep-related problems: treatment of obstructive sleep apnoea - current concepts and perspectives
Year: 2005


Obstructive sleep apnoea: who should be treated?
Source: Annual Congress 2005 - PG12 - Sleep-related problems: treatment of obstructive sleep apnoea - current concepts and perspectives
Year: 2005


Insomnia related to sleep apnoea: effect of long-term auto-adjusting positive airway pressure treatment
Source: Eur Respir J 2013; 41: 593-600
Year: 2013



Targeted hypoglossal neurostimulation for obstructive sleep apnoea: a 1-year pilot study
Source: Eur Respir J 2013; 41: 360-367
Year: 2013



Central sleep apnea
Source: Respipedia Article
Year: 2017

Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea
Source: Eur Respir J 2012; 39: 1136-1143
Year: 2012



Impact of obstructive sleep apnoea (OSA) on glucose metabolism
Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment
Year: 2007


Treatment of obstructive and central sleep apnoea in heart failure: practical options
Source: Eur Respir Rev 2007; 16: 183-188
Year: 2007



Sleep apnoea is a common occurrence in females
Source: Eur Respir J 2013; 41: 610-615
Year: 2013



Obstructive sleep apnea
Source: Respipedia Article
Year: 2017

A prospective polysomnographic study on the evolution of complex sleep apnoea
Source: Eur Respir J 2011; 38: 329-337
Year: 2011



Cognition, sleep and respiration in at-risk children treated for obstructive sleep apnoea
Source: Eur Respir J 2005; 25: 336-342
Year: 2005



Compliance in sleep apnoea therapy: influence of home care support and pressure mode
Source: Eur Respir J 2009; 33: 804-811
Year: 2009



Pathophysiology of central sleep apnea
Source: Annual Congress 2005 - Central sleep apnoea
Year: 2005

Atypical patterns in portable monitoring for sleep apnoea: features of nocturnal epilepsy?
Source: Eur Respir J 2013; 41: 368-375
Year: 2013



Are there relationships between apnoea index, nocturnal hypoxaemia, muscle strength and neuromuscular efficiency on sleep apnoea patients (OSAS)?
Source: Annual Congress 2009 - Respiratory physiotherapy assessment
Year: 2009

Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study
Source: Eur Respir J 2009; 33: 1062-1067
Year: 2009